Clinical Trials Browser

Phase 2 × Gastrointestinal Neoplasms × avelumab × Clear all

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT03812796 2019-02-05

EMERGE

Phase 2 Unknown

75 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Clinical Trials

Immunological Variables Associated to ICI Toxicity in Cancer Patients

EMERGE